Home McKesson Corp. Rating Increased to Overweight at Morgan Stanley
 

Keywords :   


McKesson Corp. Rating Increased to Overweight at Morgan Stanley

2013-10-26 15:45:19| Biotech - Topix.net

The firm currently has a $177.00 price objective on the stock. Morgan Stanley's price target indicates a potential upside of 14.20% from the company's current price.

Tags: rating increased corp morgan

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Atlantic Tropical Weather Outlook
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 9A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Depression Three Graphics
01.07Tropical Depression Three Public Advisory Number 1A
01.07Summary for Tropical Depression Three (AT3/AL032024)
01.07Eastern North Pacific Tropical Weather Outlook
More »